糖尿病合并慢性肾脏病患者的血浆肾脏健康生物标志物与死亡风险:REGARDS研究
该研究在REGARDS队列的594例糖尿病且eGFR<60 ml/min/1.73 m²患者中,分析血浆TNFR1、TNFR2、suPAR、KIM-1、YKL-40和MCP-1与全因死亡的关系。中位随访7年,332例死亡。校正人口学和临床因素后,TNFR1、TNFR2、suPAR、KIM-1和YKL-40与死亡风险升高相关;进一步校正eGFRcr-cys和UACR后,仅TNFR1、TNFR2和suPAR的关联仍存在。
要点
- 在糖尿病合并CKD患者中,血浆TNFR1、TNFR2和suPAR与全因死亡风险独立相关。
- 校正基线肾功能和尿白蛋白后,KIM-1和YKL-40与死亡的关联不再显著。
- TNFR1、TNFR2和suPAR与eGFRcr-cys的相关性较强(r=−0.72至−0.76)。
核心结论
- 在糖尿病合并CKD的成人中,较高的血浆TNFR1、TNFR2和suPAR水平与全因死亡风险相关,且独立于基线肾功能。
研究设计与样本
- REGARDS队列研究的随机样本,纳入594例糖尿病且肌酐基eGFR<60 ml/min/1.73 m²的参与者,采用Cox比例风险回归分析。
主要发现
- 中位随访7年,332例参与者死亡。
- 校正社会人口学和临床因素后,TNFR1每升高1个标准差,全因死亡HR为1.28(95%CI 1.20–1.38);TNFR2为1.61(95%CI 1.42–1.82);suPAR为1.33(95%CI 1.22–1.44);KIM-1为1.20(95%CI 1.08–1.33);YKL-40为1.23(95%CI 1.11–1.38);MCP-1无显著关联。
- 进一步校正基线eGFRcr-cys和UACR后,仅TNFR1(HR 1.16;95%CI 1.04–1.29)、TNFR2(HR 1.34;95%CI 1.12–1.60)和suPAR(HR 1.23;95%CI 1.11–1.36)的关联持续存在。
关键数值与推荐
- 基线平均年龄70岁,男性占47%,自认黑人占53%,平均eGFRcr-cys为41±13 ml/min/1.73 m²,UACR中位数(四分位距)为32(9–224)mg/g。
- TNFR1、TNFR2和suPAR与eGFRcr-cys的相关系数r=−0.72至−0.76;KIM-1、YKL-40和MCP-1的r=−0.10至−0.40。
临床怎么用
- 在糖尿病合并CKD患者中,检测血浆TNFR1、TNFR2和suPAR可能有助于识别死亡风险较高的个体。
- 这些生物标志物与肾功能和尿白蛋白的关联提示其部分反映肾脏健康状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: In diabetes and CKD, creatinine- and cystatin C–based eGFR has a strong inverse correlation with plasma TNF receptor 1, TNF receptor 2, and soluble urokinase-type plasminogen activator receptor. Higher plasma soluble TNF receptors 1 and 2 and soluble urokinase-type plasminogen activator receptor were each individually associated with mortality, independent of baseline kidney measures. BACKGROUND: Several plasma biomarkers of kidney health have been associated with CKD progression in persons with diabetes, but their associations with mortality risk have been largely unexplored. METHODS: In a random sample of 594 participants with diabetes and creatinine-based eGFR <60 ml/min per 1.73 m2 from the REGARDS cohort study, Cox proportional hazards regression was used to determine hazard ratios of mortality by plasma concentrations of soluble TNF receptors 1 and 2 (TNFR1 and TNFR2), soluble urokinase-type plasminogen activator receptor (suPAR), kidney injury molecule 1 (KIM-1), chitinase 3–like 1 (YKL-40), and monocyte chemotactic protein 1 (MCP-1). Covariates included sociodemographic and clinical factors, urine albumin-to-creatinine ratio (UACR), and creatinine- and cystatin C–based eGFR (eGFRcr-cys). RESULTS: At baseline, the mean age was 70 years, 47% were male, 53% self-identified as Black, mean±SD eGFRcr-cys was 41±13 ml/min per 1.73 m2, and median (interquartile range) UACR was 32 (9–224) mg/g. Correlations with eGFRcr-cys were stronger for TNFR1, TNFR2, and suPAR (r=−0.72 to −0.76) than for KIM-1, YKL-40, and MCP-1 (r=−0.10 to −0.40). With a median follow-up of 7 years, 332 participants died. In models adjusted for sociodemographic and clinical factors, each SD higher baseline concentration of plasma TNFR1 (hazard ratio [HR], 1.28; 95% confidence interval [CI], 1.20 to 1.38), TNFR2 (HR, 1.61; 95% CI, 1.42 to 1.82), suPAR (HR, 1.33; 95% CI, 1.22 to 1.44), KIM-1 (HR, 1.20; 95% CI, 1.08 to 1.33), and YKL-40 (HR, 1.23; 95% CI, 1.11 to 1.38) was associated with higher risk of all-cause mortality, whereas MCP-1 was not. Upon further adjustment for baseline eGFRcr-cys and UACR, only the associations for TNFR1 (HR, 1.16; 95% CI, 1.04 to 1.29), TNFR2 (HR, 1.34; 95% CI, 1.12 to 1.60), and suPAR (HR, 1.23; 95% CI, 1.11 to 1.36) persisted. CONCLUSIONS: Among adults with diabetes and CKD, higher plasma TNFR1, TNFR2, and suPAR were associated with all-cause mortality, independent of baseline kidney function.
引用
- Chen TK, Estrella MM, Katz R, et al. Plasma Biomarkers of Kidney Health and Mortality in Diabetes and Chronic Kidney Disease in the REGARDS Study. Clin J Am Soc Nephrol. 2024. PMID: 39652331. doi:10.2215/CJN.0000000000000544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。